NAGE
Niagen Bioscience, Inc.
+0.02 (+0.67%)3.02USD81.4K成交股數239M市值16.8本益比(近四季)1.9股價營收比-4.3%營收年增(近四季)2026-11-03下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 29.8M-4% | 31.5M+3% | 33.8M+32% | 34.0M+49% | 31.1M+40% | 30.5M+44% | 25.6M+31% | 22.7M+12% | 22.2M | 21.2M | 19.5M | 20.3M |
| 營業成本 | 10.5M | 11.5M | 12.1M | 12.1M | 10.9M | 11.2M | 9.3M | 9.0M | 8.7M | 8.3M | 7.5M | 8.0M |
| 毛利 | 19.3M-5% | 20.0M+3% | 21.7M+34% | 21.9M+60% | 20.2M+50% | 19.3M+49% | 16.2M+36% | 13.7M+11% | 13.5M | 12.9M | 12.0M | 12.4M |
| 毛利率 | 64.8% | 63.5% | 64.1% | 64.5% | 65.0% | 63.4% | 63.5% | 60.2% | 60.7% | 61.0% | 61.4% | 60.8% |
| 研發費用 | 1.5M | 1.5M | 1.7M | 1.8M | 1.6M | 1.3M | 1.3M | 1.3M | 2.1M | 1.2M | 1.2M | 1.4M |
| 銷售管理費用 | 7.0M | 7.2M | 7.5M | 7.1M | 7.3M | 5.2M | 6.3M | 5.7M | 5.4M | 5.4M | 5.8M | 7.3M |
| 營業利益 | 700K-78% | 1.6M-67% | 4.1M+155% | 4.2M-1755% | 3.2M-536% | 4.8M-2940% | 1.6M-240% | −256K-89% | −731K | −168K | −1.1M | −2.3M |
| 營業利益率 | 2.4% | 5.0% | 12.1% | 12.5% | 10.2% | 15.7% | 6.3% | -1.1% | -3.3% | -0.8% | -5.9% | -11.4% |
| 稅後淨利 | 963K-73% | 6.3M+25% | 4.1M+120% | 4.6M-30620% | 3.6M-834% | 5.1M+4341% | 1.9M-296% | −15K-99% | −492K | 114K | −959K | −2.2M |
| 淨利率 | 3.2% | 20.1% | 12.2% | 13.5% | 11.6% | 16.6% | 7.3% | -0.1% | -2.2% | 0.5% | -4.9% | -10.8% |
| 稀釋 EPS | 0.01-75% | 0.07+17% | 0.05+150% | 0.05 | 0.04-500% | 0.06 | 0.02-300% | 0.00-100% | -0.01 | 0.00 | -0.01 | -0.03 |
| 稀釋股數 | 82.5M | 84.6M | 85.4M | 86.6M | 86.2M | 83.2M | 77.8M | 75.6M | 75.2M | 75.0M | 75.0M | 75.0M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 66.7M | 66.5M | 64.8M | 64.1M | 60.3M | 55.5M | 32.2M | 27.7M | 27.4M | 27.2M | 26.6M | 26.3M |
| 應收帳款 | 8.6M | 13.1M | 9.7M | 8.5M | 9.7M | 7.1M | 7.1M | 7.8M | 6.6M | 5.2M | – | – |
| 存貨 | 20.6M | 24.0M | 20.4M | 18.8M | 14.4M | 11.2M | 10.5M | 11.5M | 12.5M | 14.5M | 12.6M | 12.0M |
| 總資產 | 107M | 114M | 106M | 98.1M | 91.5M | 81.3M | 56.5M | 54.0M | 54.1M | 55.0M | 53.5M | 53.2M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 24.1M | 32.0M | 29.9M | 27.5M | 27.3M | 26.0M | 22.2M | 23.3M | 25.1M | 26.5M | 26.2M | 26.0M |
| 股東權益 | 82.5M | 82.3M | 76.5M | 70.7M | 64.2M | 55.3M | 34.4M | 30.7M | 29.0M | 28.5M | 27.3M | 27.2M |
| 負債比 | 22.6% | 28.0% | 28.1% | 28.0% | 29.9% | 32.0% | 39.2% | 43.2% | 46.5% | 48.2% | 48.9% | 48.9% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −1.2M-115% | – | – | – | 7.9M | – | – | 295K | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | 2.4M | – | – | – | 0.00 | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 129M
| Consumer Products | 97.7M | 75.5% | +27.2% |
|---|---|---|---|
| Ingredients | 28.7M | 22.2% | +44.7% |
| Analytical Reference Standards And Services | 3.1M | 2.4% | +2.2% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 129M | +29.9% | 17.4M | 13.4% | 0.20 | – |
| FY2024 | 99.6M | +19.2% | 8.6M | 8.6% | 0.11 | – |
| FY2023 | 83.6M | +16.0% | −4.9M | -5.9% | -0.07 | – |
| FY2022 | 72.1M | +6.8% | −16.5M | -23.0% | -0.24 | – |
| FY2021 | 67.4M | +13.8% | −27.1M | -40.2% | -0.40 | – |
| FY2020 | 59.3M | +28.0% | −19.9M | -33.6% | -0.33 | – |
| FY2019 | 46.3M | +46.7% | −32.1M | -69.4% | -0.56 | −21.2M |
| FY2018 | 31.6M | – | −33.3M | -105.6% | -0.61 | −22.2M |